An effective response must invest in both the development of new drugs and measures to slow the emergence of resistance. A new Working Paper from the STEPS Centre and Future Health Systems, Addressing Resistance to Antibiotics in Pluralistic Health Systems, addresses the former.
The paper focuses on low and middle-income countries with pluralistic health systems, where people obtain much of their antibiotics in unorganised markets.
“If current trends continue, we could end up reliving conditions before the discovery of antibiotics, when infectious diseases were major killers,” warned Dr. Gerry Bloom one of the authors of the new paper and the convenor of the STEPS Centre’s health research, in a Project Syndicate article.
There is evidence that unroganised markets have enabled people to treat many infections and reduce mortality. However, they also encourage overuse of antibiotics and behaviour likely to encourage the emergence of resistance.
The new paper reviews a number of strategies for improving the use of antibiotics. It concludes that effective strategies need measures to ensure easy access to antibiotics, as well as those aimed at influencing providers and users of these drugs to use them appropriately.
Find out more about our work on health and disease
- STEPS Centre work on health and disease
- Transforming Health Markets in Asia and Africa: Improving quality and access for the poor Edited by Gerald Bloom, Barun Kanjilal, Henry Lucas, David Peters Routledge
- Zoonoses hot topic: Animal-to-human diseases
- Pathways for Environmental Health in Transitional Spaces: Moving Between Formality and Informality